Compare
Zeo ScientifiX, Inc. vs Dyadic International Inc vs Alpha Cognition Inc. vs Humacyte, Inc.
| Latest fiscal year | Zeo ScientifiX, Inc. ZEOX | Dyadic International Inc DYAI | Alpha Cognition Inc. ACOG | Humacyte, Inc. HUMA |
|---|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.20M | $3.09M | $10.22M | $2.04M |
| Revenue growth (YoY) | +12.5% | -11.6% | n/a | n/a |
| Gross margin | 82.1% | 24.9% (computed) | 94.1% (computed) | -376.1% (computed) |
| Operating margin | -103.6% | -232.8% | -221.7% | n/m |
| Net margin | -106.2% | -238.3% | -202.2% | n/m |
| Net income | -$5.52M | -$7.36M | -$20.67M | -$40.83M |
| EPS (Diluted) | -$0.86 | -$0.23 | -$1.18 | -$0.26 |
| Operating cash flow | -$718.0K | -$5.70M | -$20.38M | -$105.04M |
| Free cash flow | -$741.0K | n/a | -$20.67M | -$105.93M |
| Cash & equivalents | n/a | $4.62M | $66.05M | $50.50M |
| Total assets | $1.53M | $9.95M | $79.73M | $116.37M |
| Total liabilities | $2.95M | $8.71M | $17.20M | $113.26M |
| Shareholders' equity | -$1.42M | $1.23M | $62.53M | $3.11M |
| Return on year-end equity | n/a | -597.6% | -33.1% | n/m |
| Shares outstanding | 6.75M | 36.19M | 21.74M | 193.00M |
Revenue, most recent five fiscal years
| Fiscal year | Zeo ScientifiX, Inc. | Dyadic International Inc | Alpha Cognition Inc. | Humacyte, Inc. |
|---|---|---|---|---|
| Latest | $5.20M Ended 2025-10-31 | $3.09M Ended 2025-12-31 | $10.22M Ended 2025-12-31 | $2.04M Ended 2025-12-31 |
| 1 year earlier | $4.62M Ended 2024-10-31 | $3.50M Ended 2024-12-31 | n/a | $0 Ended 2024-12-31 |
| 2 years earlier | $4.56M Ended 2023-10-31 | $2.90M Ended 2023-12-31 | n/a | n/a |
| 3 years earlier | $6.49M Ended 2022-10-31 | $2.93M Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | $5.60M Ended 2021-10-31 | $2.40M Ended 2021-12-31 | n/a | n/a |